Joachim Almquist

4PUBLICATIONS
21CO-AUTHORS
AutoimmunityAllergyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|May 23, 2026
Anifrolumab Dose Regimen Selection for a Phase 3 Trial in Lupus Nephritis.

|Aug 30, 2025
AZD0449, an inhaled JAK1 inhibitor, in healthy participants and patients with mild asthma.

Anna Lundahl, Rod Hughes, Joachim Almquist

|May 01, 2024
The effect of AZD9567 vs. prednisolone on glycaemic control in patients with type 2 diabetes mellitus: Results from a phase 2a clinical trial.

Philip Ambery, Grzegorz Zajac, Joachim Almquist

|May 06, 2023
Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anifrolumab.

Weifeng Tang, Raj Tummala, Joachim Almquist

Pageof 1

Frequent Collaborators

2 joint publications

Weifeng Tang

2 joint publications

Raj Tummala

1 joint publications

Michael Hwang

1 joint publications

Wendy I White

1 joint publications

Philip Ambery

1 joint publications

Susanne Prothon

1 joint publications

Mary N Brown

1 joint publications

Szilard Nemes

1 joint publications

Karl Edman

1 joint publications

Lisa Öberg

Frequent Collaborators

2 joint publications

Weifeng Tang

2 joint publications

Raj Tummala

1 joint publications

Michael Hwang

1 joint publications

Wendy I White

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us